Capabilities and Track Record

The method, the frameworks, and the record behind them.

Every service line, the delivery method, the four Centers of Excellence, and the documented record across every phase.

Our Track Record · Delivery Proof

What rescue looks like when frameworks meet accountable delivery.

Results from the principal's documented record in prior roles, across 300+ protocols and 900 projects.

$302M
Revenue Growth · 19 Months
Company record at a global life sciences company, from new clients and existing clients who expanded their studies through the Client Delight model.
$107M
New Business from Existing Clients
Won above plan at a top-five global CRO, a different company, from existing clients who chose to do more after Client Delight delivery.
38 days
Data-Lock Acceleration
Average interim and final data locks ahead of schedule across managed programs.
98%
SOW / UAT Error Reduction
SOW and UAT set-up errors reduced across 300+ global protocols and 900 projects.
97%
Studies On-Budget
Budget adherence raised to 97% through the Project Management Center of Excellence.
94%
Sponsor Complaints Reduced
Client issues reduced across 300+ protocols, with Voice-of-Client ratings up 78%.
45%
Amendment Cycles Cut
Amendment cycles in rescued clinical trials and RWE/RWD studies, across therapeutic areas, with submissible evidence packs for FDA, EMA, PMDA, TGA, and HSA.
30%
Operational Efficiency Lift
Gain in an underperforming clinical operations division, with 15 high-priority trials delivered in 18 months.
Proven across 300+ Protocols · 900 Projects · 22+ Therapeutic Areas · Concept → Post-Market RWE
Service Lines · What We Deliver

Every capability a sponsor needs, under one delivery architecture.

Many sponsors buy clinical operations in slices: monitoring only, RWE only, commercial only. Clinical TrialRx oversees the full clinical operations lifecycle, concept through post-market, so handoffs are governed and accountability stays in one place. We do not do the work. We make sure it is done right.

Category I · Trial Oversight and Rescue

We do not replace your CRO. We make sure every phase is planned right, governed tightly, and rescued fast when it slips.

01 · Phase I → IV + RWE / RWD
Service 01

Phase I First-in-Human

Oversight of first-in-human start-up, safety review, and site readiness.

Lifecycle CoverageFIH → DSMB
Service 02

Phase II Proof of Concept

Adaptive design and interim planning, delivered with your CRO and biostatistics partners.

Design RangeAdaptive · Basket · Umbrella
Service 03

Phase III Pivotal & Registrational

Governance and rescue for multi-country pivotal trials, including an $875M Phase III program: 10,101 patients randomized at 177 sites in 26 countries.

Flagship Phase III10,101 Randomized · 26 Countries
Service 04

Phase IV Post-Market

Oversight of post-market commitments, safety surveillance, and REMS delivery.

Reference ScopePhase IV Observational · Multi-Site Global
Service 05

RWE Observational & Registries

Design and vendor oversight for observational studies, PASS, and registries.

Submission ReadyFDA · EMA · PMDA · TGA · HSA
Service 06

RWD Strategy & Data Lakes

Evidence strategy and data-partner oversight for submission-ready evidence packs.

Amendment Reduction45% Cut
RWE is not a phase. It runs across the whole lifecycle.

Every RWE/RWD engagement is scoped to the use it must survive, because evidence built for the wrong buyer fails review at the right one. See the RWE Doctrine: one asset, every phase.

Category II · Quality, Oversight & Rescue

The governance layer: risk-based monitoring, auditing, and trial rescue across every phase, every design. Phase I through Phase IV, plus RWE/RWD registries. Rescue across Phase I to IV and RWE studies.

02 · Monitor · Audit · Rescue All Phases
Service 07

Risk-Based Monitoring

Risk-based monitoring strategy and oversight of your CRO's monitoring teams, with resources allocated by site risk and AI/ML-driven anomaly detection.

Monitoring ModelRisk-Based · FSP
Service 08

Quality & Auditing

GCP audits, vendor and CRO audits, regulatory inspection readiness, and deviation root-cause analysis.

Authorities EngagedFDA · EMA · PMDA · TGA · HSA
Service 09 · Signature

Clinical Trial Rescue, Every Phase

The headline offering: rescue across Phase I to IV trials and RWE studies, from start-up stalls and enrollment shortfalls to data-integrity questions and evidence gaps. Every rescue runs on the same path.

Rescued AcrossPhases I-IV + RWE/RWD

Category III · Commercial & Win Solutions

Win more bids. Close bigger deals. Convert sponsor NOs into YES, using the same frameworks that drove a $1B / 5-year BD initiative.

03 · Bid Defense · Sales · BD
Service 10

Bid Defense Solutions

Cross-functional bid defense methodology developed and chaired at a Tier-1 global central laboratory firm. Win-strategy playbook per account, C-suite advocacy, competitive positioning.

BD Portfolio Chaired$1B / 5-Year Initiative
Service 11

Sales & BD Strategy

First Choice global sales strategy bridging BD, Operations, PM, and Commercialization. AOP alignment, pipeline architecture, top-25 pharma sponsor engagement.

Record Growth Delivered$302M in 19 Months
Service 12

Client Delight Activation

Voice of the Client (VOC) and Seven Pains diagnostic deployment, turn the seven reasons sponsors say NO into governed YES levers. Lift retention, expand wallet share, restore C-suite trust.

Sponsor Complaints Reduced94% · VoC Lift 78%
Delivery Methodology

Two processes. One path. Bid commitments carried into delivery.

Our Business Acquisition Process (BAP) and Business Execution Process (BEP) run as paired systems: every commitment made in the bid phase is operationalized into execution without the handoff failures that commonly derail sponsor engagements.

BAP, Business Acquisition Process

Staged commercial pipeline from first interest through contract. Turns sales from art into a repeatable system.

01 · Commercial
01
Interest
Inbound signal or outbound target
02
Qualify
Fit, budget, decision authority
03
Pursue
Stakeholder mapping, strategy
04
Bid
Proposal & bid defense
05
Negotiate
Terms, indemnity, SOW
06
Win
Contract → handoff to BEP

BEP, Business Execution Process

Execution counterpart to BAP. Every sales commitment is operationalized, with a seamless handoff from won to delivered.

02 · Execution
01
Define
Scope, charter, success metrics
02
Initiate
Team stand-up, KOM, governance
03
Plan
Risk register, critical path, SOP
04
Execute
Oversight of site activation, enrollment, and monitoring
05
Monitor
Metrics, reviews, amendments
06
Close
Data lock, CSR, submission-ready

5-Stage-Gate Review System

Formal evaluation at every phase, risk surfaced early rather than at data lock. Matches management intensity to project complexity.

03 · Governance
Why Clinical TrialRx · Seven Capabilities

Seven capabilities, one accountable advisor.

Sponsors often buy these as slices: a monitoring firm, an RWE shop, a bid-defense consultant, an AI/ML vendor. Clinical TrialRx brings them together as one accountable advisory practice, with a documented delivery record at each level.

Lever
What Sponsors Need
Typical Alternative
Clinical TrialRx
01
Scale ExperienceHas actually run the size of trial you are attempting
Mid-size studies, with general experience claims and few first-person scale references.
Led Phase I-IV and RWE programs end-to-end. 24,623+ patients. 1,092+ sites. 30 countries.
02
Start-Up ExperienceBrings entrepreneurial speed without losing rigor
Process-heavy approaches where method can slow delivery.
Advisor to four start-ups; two later acquired within the Salesforce and Oracle portfolios. Plus enterprise rigor.
03
AI/ML AppliedUses AI/ML inside operations, not as a bolt-on
Off-the-shelf vendor tools with limited proprietary IP.
Lead advisor on first-mover AI/ML predictability platform. Global patent protection secured.
04
End-to-End LifecycleOne accountable advisor from molecule to post-market RWE
Phase-specific specialists, with handoffs between vendors.
Concept → Submission → Post-Market RWE. One accountable advisor across every handoff.
05
Proprietary FrameworksPortable IP that scales, not generic decks
Generic methodology without an authored framework.
Authored: Service Value Added Model (SVAM) · BAP · BEP · 5-Stage-Gate Review System · Client Delight COE · RWE COE.
06
Regulatory BreadthDemonstrated submissions across major authorities
Primarily FDA-focused, with other authorities handled separately.
Experience across all five: FDA · EMA · PMDA · TGA · HSA.
07
Site · Sponsor · CRO TriadHas operated from all three sides of the table
A single vantage point: CRO-only or sponsor-only.
Built 4 CTPs at Indiana sites. Developed SVAM leading the FSP practice for a national staffing and workforce services company. Led senior roles across Tier-1 global CROs.
Portfolio by Phase · Aggregate Totals

Every phase, plus RWE. 300+ protocols. 22+ therapeutic areas.

Clinical operations directed across every phase of the drug development lifecycle. The portfolio below reports aggregate totals by phase, the scale of trials the principal has been responsible for, not individual sponsor engagements.

01
Phase I, First-in-HumanFIH · Dose Escalation · PK/PD · Safety Cohort
Early Phase
Safety + PK/PD
Multi-Site First-in-Human Programs
Dose Escalation · MAD/SAD · Biomarker
02
Phase II, Proof of ConceptPOC · Dose Finding · Signal Detection
Mid Phase
Efficacy Signal
Adaptive · Basket · Umbrella Designs
Biomarker Integration · Bayesian Endpoints
03
Phase III, Pivotal & RegistrationalMulti-Therapeutic · Multi-Country · Submission-Bound
Flagship Phase III
$875M Program
10,101 randomized · 177 sites
26 Countries · Multiple Therapeutic Areas
04
Phase IV, Post-Market & ObservationalLabel Expansion · Safety Surveillance · RMP/REMS
Post-Market
Long-Term Follow-Up
Observational · Pragmatic Phase IV
Multi-Indication · Signal Detection
05
RWE / RWD Programs + Trial RescueRegistries · NIS · PASS · PRO · International Rescues
30+ Rescues
Every Phase
Disease & Product Registries
FDA · EMA · PMDA · TGA · HSA Submissions
Global Reach

Operational across six continents, governed from one delivery architecture.

Global trial rescue requires country-by-country regulatory fluency, IRB/ethics pathways, import licenses, insurance requirements, translation cycles. Execution has been overseen across every region below.

Europe
Asia Pacific
North America
Latin America
Africa
Middle East
Delivery Promise · The Operating Thesis
"Right the First Time, On-Time, On-Target."
What Clinical TrialRx delivers to every sponsor, so our clients Out-Pace in Their Space.

Right the First Time: the bid, the SOW, and the budget match the protocol before the first site opens.

Client Delight + Value + Trust = YES
The operating philosophy behind every engagement
Principal Portfolio · Documented Track Record

The metrics behind the methodology.

Every framework on this site was forged in delivery: global trials, global commercial mandates, start-up advisory work, and 30+ international rescues. The portfolio below summarizes the principal's documented career record.

$107M
New Business, Existing Clients
Above plan · top-five global CRO
$302M
Revenue Growth
19 months · company record · new and returning clients
30+
Rescues
Including 7 Phase II and III rescues
54/157
Reports Led
Direct / Dotted-Line · 27 PIP Turnarounds
22+
Therapeutic Areas
Oncology · CV · CNS · Rare Disease + more
30
Countries
Six continents · 1,092+ sites
I-IV+RWE
Full Lifecycle
Concept → submission → post-market

Portfolio Totals

Across All Engagements · Aggregate
Total Studies Directed

The Trial Portfolio

Clinical trial accountability across every phase, every geography, and every regulatory pathway, from concept through submission through post-market surveillance.

300+Protocols Managed
900Projects Delivered
30+Trials and RWE Studies Rescued
24,623+Patients Enrolled
1,092+Clinical Sites
I-IV+RWEAll Phases and RWE
Commercial Leadership · Career Record

Revenue Growth · Commercial Leadership

Commercial results from two separate senior roles at two different life sciences companies: a company-record $302M in revenue growth over 19 months from new and returning clients, and $107M in new business above plan from existing clients. Both were driven by the Client Delight model, alongside PM-COE buildout across three continents.

$302MRevenue Growth
$107MNew Business, Existing Clients
4PM-COEs Built
78%VoC Lift
$1BBD Initiative Chaired
3Continents
Delivery Excellence Proof · 300+ Protocols · 900 Projects
38 days
Ahead of Schedule
Average interim & final data-lock acceleration across managed programs
98%
SOW / UAT Error Reduction
Set-up errors, across 300+ global protocols and 900 projects
97%
Studies On-Budget
Budget adherence through the PM Center of Excellence
94%
Sponsor Complaints Reduced
Across 300+ protocols · Voice-of-Client ratings up 78%
Engage Clinical TrialRx

Your trial is off-course.
We put it back on target.

Start with a no-obligation rescue assessment. We will diagnose where your program has drifted, map the VOC and Seven Pains failure points actively dragging it, and show you a governed path to recovery in 30 minutes.

Headquarters
2 East Main Street
Pittsboro, IN 46167
Remote delivery worldwide · on site when needed